Erythropoietin und Hypertonie
- 1 September 1988
- journal article
- abstracts
- Published by Springer Nature in Klinische Wochenschrift
- Vol. 66 (18) , 914-919
- https://doi.org/10.1007/bf01728954
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Therapie der renalen Anämie mit rekombinantem humanem ErythropoietinDeutsche Medizinische Wochenschrift (1946), 1988
- HYPERTENSION, BLOOD VISCOSITY, AND CARDIOVASCULAR MORBIDITY IN RENAL FAILURE: IMPLICATIONS OF ERYTHROPOIETIN THERAPYThe Lancet, 1988
- RECOMBINANT ERYTHROPOIETIN AND BLOOD PRESSUREThe Lancet, 1987
- Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis.BMJ, 1987
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSISThe Lancet, 1986
- Hemodynamics of Uremic AnemiaCirculation, 1971
- Longitudinal Gradients in Periarteriolar Oxygen TensionCirculation Research, 1970
- Hemodynamic Responses to Oxygen Breathing in Children with Severe AnemiaCirculation, 1969
- THE DETERMINATION OF BLOOD VISCOSITY IN MAN BY A METHOD BASED ON POISEUILLE'S LAWJournal of Clinical Investigation, 1953